Angiodynamics reports fiscal 2021 fourth quarter and full-year financial results

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced financial results for the fourth quarter and fiscal year 2021, which ended may 31, 2021. “the angiodynamics team demonstrated excellent performance, resilience, and strong execution in what was a uniquely challenging year. we saw the pressure from covid-19 gradually alleviate over t
ANGO Ratings Summary
ANGO Quant Ranking